ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Loss of ER-mitochondria contacts drives therapy resistance in neuroblastoma||Children's Hospital of Philadelphia / Michael Hogarty, MD||Innovation Grants||2021||Pennsylvania|
|Investigating Epigenetic Mechanisms of Response to Allogenic CAR T Cell Therapy||St. Jude Children's Research Hospital / Caitlin Zebley, MD/PhD||Young Investigator Grants||2021||Tennessee|
|Targeting tumor associated macrophages in metastatic Ewing sarcoma (ES)||New York Medical College / Mitchell Cairo, MD||Innovation Grants||2021||New York|
|Hematopoietic Stem And Progenitor Cells Sustain Inflammation And Promote Relapse In The AML Niche||Children's Hospital of Philadelphia / Ding-Wen (Roger) Chen, PhD||Young Investigator Grants||2021||Pennsylvania|
|A leukemia organoid platform for dissection and targeting of tumor-niche interactions||Columbia Institute for Cancer Genetics / Adolfo Ferrando, MD/PhD||Innovation Grants||2021||New York|
|STING Pathway Activation: The Missing Link between Genomic Instability and Antitumor Immunity in Osteosarcoma||University of California San Francisco / Elizabeth Young, MD||Young Investigator Grants||2021||California|
|Phosphopeptides as shared targets for donor derived T cell therapy of AML||Memorial Sloan-Kettering Cancer Center / Richard O'Reilly, MD||Innovation Grants||2021||New York|
|Activating Metabolic Pathways to Increase the Persistence of Leukemia Targeting T Cells||Children's Hospital of Pittsburgh / Erica Braverman, MD||Young Investigator Grants||2021||Pennsylvania|
|Role of H3.3-G34R mutation in pediatric high-grade glioma||University of Texas M.D. Anderson Cancer Center / Jian Hu, PhD||Innovation Grants||2021||Texas|
|Redefining Osteosarcoma Metastases as Chronic Non-healing Lung Wounds: Implications for Developing Novel Therapies||Research Institute at Nationwide Children's Hospital / James Reinecke, MD/PhD||Young Investigator Grants||2021||Ohio|